Megan T. Sniecinski
Chief Operating OfficerMs. Megan T. Sniecinski is Chief Operating Officer of Praxis Precision Medicines, Inc. from January 1, 2026 and was its Chief Business Officer since December 2021 until December 2025. She had been the Senior Vice President and Chief Business Officer of BioCryst Pharmaceuticals, Inc. since July 01, 2019 until August 09, 2021. Ms. Sniecinski joined BioCryst in July 2019 as Chief Business Officer. She served as Senior Vice President of Business Operations and Program Management at PTC Therapeutics, Inc. since June 14, 2017 until 2019 and also served as its Secretary. Ms. Sniecinski was responsible for program management of PTC Therapeutics's development program teams and alliance partnerships, driving alignment and execution of cross-functional business plans to deliver on company objectives, as well as PTC's IT and Facilities organizations. Ms. Sniecinski joined PTC in September 2014, as the Vice President of Business Operations and held that role until 2017. Prior to joining PTC, Ms. Sniecinski held various positions at Merck & Co., Inc., a global health care company, from 2002 to 2014, most recently as Chief of Staff to the President and Director of Business Development and Strategic Partnerships with Merck Vaccines, where she managed Merck's European Joint Venture vaccine partnership, Sanofi Pasteur MSD and a second partnership alliance to develop and commercialize a pediatric combination vaccine for the US and Europe. With experience at Merck, she has a strong understanding of global pharmaceutical operations, including experience in Commercial Operations, Medical Affairs, Clinical Development, Manufacturing Operations, Supply Chain and Operational Excellence. Ms. Sniecinski received her B.S. in Chemical Engineering from the University of Virginia and an Executive M.B.A. from the Wharton School of the University of Pennsylvania.
Positions
- Company NamePraxis Precision Medicines, Inc.Stock CodePRAXPositionChief Operating OfficerColleagues
- MSMarcio Silva De'SouzaPresident, CEO & Director
- DJDean Jonathan MitchellIndependent Chairman of the Board
- TETimothy Edwin KellyCFO & Treasurer
- ANAlex NemiroffGeneral Counsel & Secretary
- SPSteven PetrouCo-Founder and President of Research & Development
- WDWilliam Douglas YoungIndependent Director
- GNGregory NordenIndependent Director
- JAJeffrey Allan ChodakewitzIndependent Director
